Aptevo Therapeutics Introduces New Adaptir™ Bispecific Antibody Candidate Intended for the Treatment of Solid Tumors

    NEXT STORY
    Global Medical Devices Market Report 2019-2022 – A $521+ Billion Opportunity Analysis
    PREV STORY
    HOOKIPA to Present Data Demonstrating the Potential of its TheraT® Technology at the Upcoming CICON Conference in Paris
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immunicum AB (publ) Announces Upcoming Investor Events in January

    Press Release 22 January 2019 Immunicum AB (publ) Announces Upcoming Investor Events in January ...

    author_avatar
    NASDAQ Market News

    Oculogica Receives FDA Marketing Authorization for EyeBOX®, the First Non-Invasive, Baseline-Free Test for Concussion

    author_avatar
    NASDAQ Market News

    DBV Technologies Announces Results from Phase II Study of Viaskin Milk in Milk-Allergic Patients

    Press ReleaseMontrouge, France, February 26, 2018                                                                                                                                                                           DBV Technologies Announces Results from Phase ...

    author_avatar
    NASDAQ Market News